The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs.
MDC Connects 2021: A Guide to Complex Medicines is a series of webinars exploring the opportunities and challenges presented by this new class of medicines, and takes you through the steps to take an idea from concept to the clinic.
In this final session, a panel of experts will describe how to prepare for the clinic; to formulate, scale-up and navigate the regulatory approval process.
Agenda
The advantages of good formulation – Claire Patterson (SEDA Pharmaceutical Development Services)
Overcoming the challenges of scaling up a complex medicine – Graham Worrall and Emily Port (CPI)
Everything you want to know about development, but were afraid to ask! – Alan Boyd (Boyds)
Recording
Slides
The advantages of good formulation
Overcoming the challenges of scaling up a complex medicine
Everything you want to know about development, but were afraid to ask!
Learn more about complex medicines – Claire Patterson at Seda Pharmaceutical Development Services offers clarity to the scope of the term ‘complex medicines’ – read the blog.
